Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream genes. At the cellular level, p53 induces apoptosis, cell cycle arrest and senescence. A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arrest. To decipher the functional importance of these pathways in spontaneous tumorigenesis, we used homologous recombination to generate mice with mutant p53-R172P (the mouse equivalent of R175P in humans). Mice inheriting two copies of this mutation (Trp53(515C/515C)) escape the early onset of thymic lymphomas that characterize Trp53-null mice. At 7 months of age, 90% of Trp53-null mice had died, but 85% of Trp53(515C/515C) mice were alive and tumor-free, indicating that p53-dependent apoptosis was not required for suppression of early onset of spontaneous tumors. The lymphomas and sarcomas that eventually developed in Trp53(515C/515C) mice retained a diploid chromosome number, in sharp contrast to aneuploidy observed in tumors and cells from Trp53-null mice. The ability of mutant p53-R172P to induce a partial cell cycle arrest and retain chromosome stability are crucial for suppression of early onset tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells harboring this mutation (p53P/P) are incapable of activating p53-dependent apoptosis59, but the p53-dependent cellular senescence pathway is intact as induction of telomere dysfunction through overexpression of TRF2-DN in these cells led to dramatic reduction of cellular proliferation and the appearance of senescent cells that stain positive for SA-β-Gal58.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“Mice homozygous for the p.R172P mutation (equivalent to the human p.R175P alteration) exhibit defects in TP53‐dependent apoptosis but retain a partial cell cycle checkpoint function [44].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 1×
“p53-R172P weakly induced Cdkn1a (encoding p21), a crucial target of p53 in cell cycle contro”
Backgroundp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“gif" NDATA ITEM> ]> The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream gene”
BackgroundMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · cited 1×
“Trp53 -null mice succumb to early tumorigenesis, predominantly thymic lymphoma”
Backgroundp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · cited 1×
“To confirm this finding, we measured apoptosis in freshly isolated thymocytes after γ-radiatio”
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 1×
“gif" NDATA ITEM> ]> The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream gene”
BackgroundThymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · cited 1×
“Trp53 -null mice succumb to early tumorigenesis, predominantly thymic lymphoma”
BackgroundGenetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986 · cited 1×
“Genomic instability promotes tumorigenesis in multiple setting”
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880 · cited 1×
“p53-dependent apoptosis is extremely important in controlling tumor progression in different model”
BackgroundTargeted oncogene activation by site-specific recombination in transgenic mice.
Lakso, M., Sauer, B., Mosinger, B., Lee, E. J., Manning, R. W., Yu, S. H., Mulder, K. L., & Westphal, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6232 · Cited by 680 · cited 1×
“We crossed mice with germline transmission of the targeted allele to CMV-cre transgenic mic”
MethodApaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660 · cited 1×
“MEFs infected with a retrovirus expressing E1A were exposed to adriamycin or deprived of serum, conditions known to trigger p53-dependent apoptosi”
MethodDissecting p53 tumor suppressor functions in vivo
Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00047-8 · Cited by 485 · cited 1×
“p53-dependent apoptosis is extremely important in controlling tumor progression in different model”
Background(1993) · PubMed · Cited by 469
Venkatachalam, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., & Vousden, K. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00418.x · Cited by 301 · cited 1×
“A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arres”
BackgroundAbrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
Lowe, S. W., Jacks, T., Housman, D. E., & Ruley, H. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2026 · Cited by 287 · cited 1×
“To determine whether the p53-R172P mutant was defective in causing apoptosis, we used the adenovirus E1A oncoprotein to sensitize MEFs to p53-dependent apoptosi”
MethodDifferential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 275 · cited 1×
“A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arres”
BackgroundFunctional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation
Kapoor, M., & Lozano, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2834 · Cited by 211
Self-citationHigh metastatic potential in mice inheriting a targeted p53 missense mutation
Liu, G., McDonnell, T. J., Montes de Oca Luna, R., Kapoor, M., Mims, B., El-Naggar, A. K., & Lozano, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4174 · Cited by 199 · cited 1×
“We cloned a PGK- neo r cassette flanked by two lox P sequences into the second Acc I site of intron 4 of a Trp53 genomic fragmen”
MethodSelf-citationLoss of p53 and centrosome hyperamplification
Tarapore, P., & Fukasawa, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205707 · Cited by 189
Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway
Tarapore, P., Horn, H. F., Tokuyama, Y., & Fukasawa, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204424 · Cited by 161
Lee, Y., Chong, M. J., & McKinnon, P. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06687.2001 · Cited by 127 · cited 1×
“As expected, apoptosis was widespread in wild-type embryos but was not detected in the Trp53 -null embryo”
BackgroundHundley, J. E., Koester, S. K., Troyer, D. A., Hilsenbeck, S. G., Subler, M. A., & Windle, J. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.723 · Cited by 92
No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma
Liao, M.-J., Zhang, X.-X., Hill, R., Gao, J., Qumsiyeh, M. B., Nichols, W., & Van Dyke, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3495 · Cited by 84
V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht, M., & Jacks, T. (1998) · PubMed · Cited by 59
Genetic instability in animal tumorigenesis models.
Donehower, L. A. (1997) · PubMed · Cited by 41
Regulation of genomic instability in preneoplastic cells.
Td, T. (1996) · PubMed · Cited by 6
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
“Despite being completely deficient in p53-driven apoptosis, these mice are still reasonably well protected from tumor development (Liu et al., 2004).”
BackgroundCell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
“This surprising result suggests that the growth arrest and chromosome stability functions of p53 provide tumour suppressor function even in the absence of its role in apoptosi”
BackgroundVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
“1 ), including apoptosis, cell-cycle arrest, maintenance of genomic stability and senescenc”
BackgroundKastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Senescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766
Metadata
- Authors
- Liu, G., Parant, J. M., Lang, G., Chau, P., Chavez-Reyes, A., El-Naggar, A. K., Multani, A., Chang, S., & Lozano, G.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Lozano, Guillermina
- Venue
- Nature Genetics
- Published
- 2003-12-21
- Volume
- 36
- Issue
- 1
- Pages
- 63-68
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1970378023
- Cited by
- 325
- References
- 30
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 15 · 2018: 9 · 2017: 11 · 2016: 16 · 2015: 5 · 2014: 15 · 2013: 18 · 2012: 19
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kadoorie Charitable Foundation
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, chromosome stability, apoptosis, tumor suppression, spontaneous tumor development, thymic lymphoma, sarcoma, aneuploidy, cell cycle arrest, senescence, diploidy
- MeSH terms
- Animals, Cell Cycle, Lymphoma, Mice, Mutant Strains, Ploidies, Genes, p53, Apoptosis, Chromosomal Instability, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.